SFSIG
MRNA icon

San Francisco Sentry Investment Group’s Moderna MRNA Stock Holding History

San Francisco Sentry Investment Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$70K Hold
300
– – 0.04% 325
2021
Q1 		$39K Buy
300
+100
+50% +$14.5K 0.02% 411
2020
Q4 		$21K Hold
200
– – 0.01% 460
2020
Q3 		$14K Hold
200
– – 0.01% 464
2020
Q2 		$13K Buy
+200
New +$11K 0.01% 469

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

San Francisco Sentry Investment Group's MRNA Position: Q2 2021 in Review

San Francisco Sentry Investment Group held its Moderna (MRNA) position steady in Q2 2021 at 300 shares worth $70K. The position accounts for 0.04% of the portfolio, ranked #325.

San Francisco Sentry Investment Group first reported a position in MRNA in Q2 2020 and has held it in 5 quarters since. 904 funds tracked by Wall St. Rank hold MRNA as of Q2 2021.

  • San Francisco Sentry Investment Group held 300 shares of Moderna worth $70K as of Q2 2021.
  • San Francisco Sentry Investment Group left its Moderna share count unchanged in Q2 2021.
  • Moderna made up 0.04% of San Francisco Sentry Investment Group's portfolio in Q2 2021, its #325 holding.
  • San Francisco Sentry Investment Group first reported a position in Moderna in Q2 2020 and has held it in 5 quarters since.
  • 904 funds tracked by Wall St. Rank held Moderna as of Q2 2021.

Based on San Francisco Sentry Investment Group's 13F filing for Q2 2021, filed 2 Aug 2021.